Cargando…
Cardiovascular Concentration-Effect Relationships of Amodiaquine and its Metabolite Desethylamodiaquine: Clinical and Pre-clinical Studies
BACKGROUND: Amodiaquine is a 4-aminoquinoline antimalarial used extensively for the treatment and prevention of malaria. Orally administered amodiaquine is largely converted to the active metabolite desethylamodiaquine. Oral amodiaquine can cause bradycardia, hypotension, and electrocardiograph (ECG...
Autores principales: | Chan, Xin Hui S, Chotsiri, Palang, Capel, Rebecca A, Pike, James, Hanboonkunupakarn, Borimas, Lee, Sue J, Hanafiah, Maryam, Win, Yan Naung, Cremer, Maegan, Kiechel, Jean-René, Ogutu, Bernhards, Taylor, Walter RJ, Burton, Rebecca-Ann B, Tarning, Joel, White, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614325/ https://www.ncbi.nlm.nih.gov/pubmed/36256474 http://dx.doi.org/10.1111/bcp.15569 |
Ejemplares similares
-
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
por: Chan, Xin Hui S., et al.
Publicado: (2021) -
High-throughput quantitation method for amodiaquine and desethylamodiaquine in plasma using supported liquid extraction technology
por: Kaewkhao, Karnrawee, et al.
Publicado: (2021) -
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
por: Anyorigiya, Thomas A., et al.
Publicado: (2021) -
Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
por: Anyorigiya, Thomas A., et al.
Publicado: (2021) -
Fixed dose artesunate amodiaquine – a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine
por: Ogutu, Bernhards, et al.
Publicado: (2014)